MindWalk Holdings Corp.
HYFT•NASDAQ•Healthcare•Biotechnology

About MindWalk Holdings

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOJennifer Bath
Founded1983
IPO DateJanuary 3, 2017
Employees102
CountryUnited States
Fiscal YearMay - April

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyCAD - CAD
TypeStock

Contact Information

Websitewww.mindwalkai.com
Phone800 620 4187
Address
Industrious 823 Congress Ave, Suite 300 Austin, Texas 78701 United States

Corporate Identifiers

CIK0001715925
CUSIP45257F200
ISINCA6026871054
SIC2834

Leadership Team & Key Executives

Dr. Jennifer Lynne Bath Ph.D.
Chief Executive Officer, President and Non-Independent Director
Kari Graber
Vice President of Commercial Services
Dr. Shuji Sato
Vice President of Innovative Solutions
Richard Scott Areglado
Chief Financial Officer
Dirk Van Hyfte M.D., Ph.D.
Chief Technology Officer
Frederic Chabot
Head of Corporate Development
Ingrid Brands M.D., Ph.D.
Chief Innovation and Strategy Officer
Dr. Thomas Lynch Ph.D.
Chief Business Officer
Lori Anderson
Vice President of Brand Marketing and Creative